Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation (Q66403844)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation |
clinical trial |
Statements
Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation (English)
0 references
2 May 2016
0 references
15 July 2018
0 references
22
0 references
18 year
0 references